Literature DB >> 15518237

Wnt signaling: physiology and pathology.

Céline Prunier1, Barbara A Hocevar, Philip H Howe.   

Abstract

Signaling by the Wnt family of secreted glycoproteins has been demonstrated to be essential both in normal embryonic development and in the pathogenesis of a variety of diseases, including cancer. This signaling pathway is exquisitely regulated by a large and complex array of proteins, which act as agonists or antagonists of signal transduction, modulating the Wnt signal extracellularly, in the cytoplasm and in the nucleus. Here, we will briefly review the canonical Wnt signaling pathway and consider molecular defects in Wnt signaling components known to promote uncontrolled cell growth following induction of Wnt signaling. We will also focus on two recently identified factors in this pathway, that seem to act as Wnt signaling antagonists, one functioning in the cytoplasm called Disabled-2 and the other in the nucleus named Chibby.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15518237     DOI: 10.1080/08977190410001720860

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  35 in total

Review 1.  Diseases of Wnt signaling.

Authors:  Mark L Johnson; Nalini Rajamannan
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 6.514

2.  Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.

Authors:  Valeriya Lyssenko; Roberto Lupi; Piero Marchetti; Silvia Del Guerra; Marju Orho-Melander; Peter Almgren; Marketa Sjögren; Charlotte Ling; Karl-Fredrik Eriksson; Asa-Linda Lethagen; Rita Mancarella; Göran Berglund; Tiinamaija Tuomi; Peter Nilsson; Stefano Del Prato; Leif Groop
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 3.  Review paper: origin and molecular pathology of adrenocortical neoplasms.

Authors:  M Bielinska; H Parviainen; S Kiiveri; M Heikinheimo; D B Wilson
Journal:  Vet Pathol       Date:  2009-03       Impact factor: 2.221

4.  Dab2, a negative regulator of DC immunogenicity, is an attractive molecular target for DC-based immunotherapy.

Authors:  Md Selim Ahmed; Se Eun Byeon; Yideul Jeong; Mohammad Alam Miah; Md Salahuddin; Yoon Lee; Sung-Soo Park; Yong-Soo Bae
Journal:  Oncoimmunology       Date:  2015-02-03       Impact factor: 8.110

5.  Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways.

Authors:  Martha L Slattery; Roger K Wolff; Karen Curtin; Frank Fitzpatrick; Jennifer Herrick; John D Potter; Bette J Caan; Wade S Samowitz
Journal:  Mutat Res       Date:  2008-10-15       Impact factor: 2.433

6.  Silencing of the Drosophila ortholog of SOX5 leads to abnormal neuronal development and behavioral impairment.

Authors:  Airong Li; Basavaraj Hooli; Kristina Mullin; Rebecca E Tate; Adele Bubnys; Rory Kirchner; Brad Chapman; Oliver Hofmann; Winston Hide; Rudolph E Tanzi
Journal:  Hum Mol Genet       Date:  2017-04-15       Impact factor: 6.150

Review 7.  The emerging genetic architecture of type 2 diabetes.

Authors:  Alessandro Doria; Mary-Elizabeth Patti; C Ronald Kahn
Journal:  Cell Metab       Date:  2008-09       Impact factor: 27.287

8.  The inhibitory effects of Disabled-2 (Dab2) on Wnt signaling are mediated through Axin.

Authors:  Y Jiang; C Prunier; P H Howe
Journal:  Oncogene       Date:  2007-10-08       Impact factor: 9.867

9.  The Synergistic Enhancement of Cloning Efficiency in Individualized Human Pluripotent Stem Cells by Peroxisome Proliferative-activated Receptor-γ (PPARγ) Activation and Rho-associated Kinase (ROCK) Inhibition.

Authors:  Nasim-Sadat Kajabadi; Ali Ghoochani; Maryam Peymani; Kamran Ghaedi; Abbas Kiani-Esfahani; Motahareh-Sadat Hashemi; Mohammad Hossein Nasr-Esfahani; Hossein Baharvand
Journal:  J Biol Chem       Date:  2015-09-02       Impact factor: 5.157

10.  Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models.

Authors:  Ying Chen; Yang Hu; Ti Zhou; Kevin K Zhou; Robert Mott; Mingyuan Wu; Michael Boulton; Timothy J Lyons; Guoquan Gao; Jian-xing Ma
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.